Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DE REIJKE, Theo M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 52

  • Page / 3
Export

Selection :

  • and

New Developments in Prostate Cancer Treatment: Focus on Hormonal Therapy (STOP-3)DE REIJKE, Theo M.BJU international. Supplement (Print). 2012, Vol 109, Num 6, issn 1465-5101, 43 p.Conference Proceedings

Drivers for change in the management of prostate cancer ― Guidelines and new treatment techniquesWOLFF, J. M; MASON, M.BJU international. Supplement (Print). 2012, Vol 109, Num 6, pp 33-41, issn 1465-5101, 9 p.Conference Paper

Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapySCHULMAN, C; IRANI, J; AAPRO, M et al.BJU international. Supplement (Print). 2012, Vol 109, Num 6, pp 13-21, issn 1465-5101, 9 p.Conference Paper

Prognostic factor analysis in patients with advanced prostate cancer treated by castration plus Anandron or placebo: A final updateDE REIJKE, Theo M; DEROBERT, Eric.European urology. 2002, Vol 42, Num 2, pp 139-146, issn 0302-2838Article

EORTC prostate cancer trials: what have we learnt?DE REIJKE, Theo M; COLLETTE, Laurence.Critical reviews in oncology/hematology. 2002, Vol 43, Num 2, pp 159-165, issn 1040-8428Article

Prostate specific antigen: A prognostic marker of survival in good prognosis metastatic prostate cancer? (EORTC 30892). CommentaryCOLLETTE, Laurence; DE REIJKE, Theo M; SCHRÖDER, Fritz H et al.European urology. 2003, Vol 44, Num 2, pp 182-189, issn 0302-2838, 8 p.Article

New developments in castrate―resistant prostate cancerSHORE, N; MASON, M; DE REIJKE, Th. M et al.BJU international. Supplement (Print). 2012, Vol 109, Num 6, pp 22-32, issn 1465-5101, 11 p.Conference Paper

EORTC-GU group expert opinion on metastatic renal cell cancerDE REIJKE, Theo M; BELLMUNT, Joaquim; VAN POPPEL, Hein et al.European journal of cancer (1990). 2009, Vol 45, Num 5, pp 765-773, issn 0959-8049, 9 p.Article

Local tract metastasis of prostatic adenocarcinoma 8 years after 125iodine brachytherapyWIERSINGA, Willem Joost; DE REIJKE, Theo M; BLANK, Leo E. C. M et al.The Journal of urology. 2001, Vol 166, Num 3, issn 0022-5347, p. 995Conference Paper

Rectal squamous cell carcinoma 11 years after brachytherapy for carcinoma of the prostateYURDAKUL, Gülühan; DE REIJKE, Theo M; BLANK, Leo E. C. M et al.The Journal of urology. 2003, Vol 169, Num 1, issn 0022-5347, p. 280Article

Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rateCAUBERG, Evelyne C. C; MAMOULAKIS, Charalampos; DE LA ROSETTE, Jean J. M. C. H et al.World journal of urology (Print). 2011, Vol 29, Num 4, pp 503-509, issn 0724-4983, 7 p.Article

BCG dose reduction by decreasing the instillation frequency : Effects on local Th1/Th2 cytokine responses in a mouse modelDE BOER, Elizabeth C; ROOYAKKERS, Sietske J; SCHAMHART, Denis H. J et al.European urology. 2005, Vol 48, Num 2, pp 333-338, issn 0302-2838, 6 p.Article

Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary GroupCOLLETTE, Laurence; VAN ANDEL, George; BOTTOMLEY, Andrew et al.Journal of clinical oncology. 2004, Vol 22, Num 19, pp 3877-3885, issn 0732-183X, 9 p.Article

Reduction of unnecessary use of indwelling urinary cathetersJANZEN, Jolien; BUURMAN, Bianca M; SPANJAARD, Lodewijk et al.BMJ quality & safety (Print). 2013, Vol 22, Num 12, pp 984-988, issn 2044-5415, 5 p.Article

Androgen deprivation therapy: past, present and futureSCHRÖDER, F; CRAWFORD, E. D; AXCRONA, K et al.BJU international. Supplement (Print). 2012, Vol 109, Num 6, pp 1-12, issn 1465-5101, 12 p.Conference Paper

Three-Year Outcome following Holmium Laser Enucleation of the Prostate Combined with Mechanical Morcellation in 330 Consecutive Patients. CommentaryVAVASSORI, Ivano; VALENTI, Sergio; NASPRO, Richard et al.European urology. 2008, Vol 53, Num 3, pp 599-606, issn 0302-2838, 8 p.Article

Optimal management of metastatic castration-resistant prostate cancer: Highlights from a European Expert Consensus PanelFITZPATRICK, John M; BELLMUNT, Joaquim; EFSTATHIOU, Eleni et al.European journal of cancer (1990). 2014, Vol 50, Num 9, pp 1617-1627, issn 0959-8049, 11 p.Article

Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections: A Randomized, Double-blind, Noninferiority Trial in Postmenopausal WomenBEEREPOOT, Marielle A. J; RIET, Gerben Ter; GEERLINGS, Suzanne E et al.Archives of internal medicine (1960). 2012, Vol 172, Num 9, pp 704-712, issn 0003-9926, 9 p.Article

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)BOLIA, Michel; POPPEL, Hein Van; DE BEEK, Cees Van et al.Lancet (British edition). 2012, Vol 380, Num 9858, pp 2018-2027, issn 0140-6736, 10 p.Article

Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy. CommentaryCHOO, Richard; PEARCE, Andrew; DANJOUX, Cyril et al.European urology. 2007, Vol 52, Num 6, pp 1645-1652, issn 0302-2838, 8 p.Article

Phase i clinical and pharmacokinetic study of Kahalalide F in patients with advanced androgen refractory prostate cancerRADEMAKER-LAKHAI, Jeany M; HORENBLAS, Simon; MEINHARDT, Willem et al.Clinical cancer research. 2005, Vol 11, Num 5, pp 1854-1862, issn 1078-0432, 9 p.Article

Computed Tomography-Urography for Upper Urinary Tract Imaging: Is It Required for All Patients Who Present with Hematuria?CAUBERG, Evelyne C. C; NIO, C. Y; DE LA ROSETTE, Jean M. C. H et al.Journal of endourology. 2011, Vol 25, Num 11, pp 1733-1740, issn 0892-7790, 8 p.Article

Differences in Time to Disease Progression Do Not Predict for Cancer-specific Survival in Patients Receiving Immediate or Deferred Androgen-deprivation Therapy for Prostate Cancer: Final Results of EORTC Randomized Trial 30891 with 12 Years of Follow-upSTUDER, Urs E; WHELAN, Peter; WIMPISSINGER, Florian et al.European urology. 2014, Vol 66, Num 5, pp 829-838, issn 0302-2838, 10 p.Article

BEHAVIOR OF LIPIODOL MARKERS DURING IMAGE GUIDED RADIOTHERAPY OF BLADDER CANCERCHAI, Xiangfei; VAN HERK, Marcel; VAN DE KAMER, Jeroen B et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 1, pp 309-314, issn 0360-3016, 6 p.Article

Optimizing Prostate Cancer Detection: 8 Versus 12-Core Biopsy ProtocolDE LA ROSETTE, Jean J. M. C. H; WINK, Margot H; MAMOULAKIS, Charalampos et al.The Journal of urology. 2009, Vol 182, Num 4, pp 1329-1336, issn 0022-5347, 8 p., 1Article

  • Page / 3